Nephritis- urinary system disease

download Nephritis- urinary system disease

of 18

Transcript of Nephritis- urinary system disease

  • 7/30/2019 Nephritis- urinary system disease

    1/18

    NEPHRITISTubulointerstitial

    Nephritis (TIN)

    Ms. Harpreet Kaur

    Lecturer

  • 7/30/2019 Nephritis- urinary system disease

    2/18

    DEFINITION

    Nephritis suggests a noninfectious inflammatory

    process that involves the nephron .

    Term nephritis is also applied to a group of unrelated

    inflammatory disorders known collectivelyas tubulointerstitial nephritis (TIN) . TIN initially

    affects mainly the interstitium and renal tubules

    Nephritis is term used to clinically denote a child

    with hypertension, decreased renal function,

    hematuria, and edema.

  • 7/30/2019 Nephritis- urinary system disease

    3/18

    ETIOLOGY

    Antigen-antibody complexes trapped in the renal

    parenchyma : process of inflammation and cell

    proliferation, in which endothelial or epithelial cells

    are stimulated to proliferate in varying degrees, isinitiated, which damages normal renal tissue

    An infection, a drug, a metabolic abnormality

  • 7/30/2019 Nephritis- urinary system disease

    4/18

    EPIDEMIOLOGY

    TIN is very rare in children younger than age 5

    years. Acute TIN can potentially occur in

    people of any age. Chronic TIN tends to occur

    late in childhood or adolescence

  • 7/30/2019 Nephritis- urinary system disease

    5/18

    CLINICAL MANIFESTATIONS

    Allergic manifestations, most have fever

    Nonspecific symptoms, such as malaise, fever,

    anorexia, or weakness, may be present

    Facial swelling and perioral, or pedal edema orascites

    Symptoms of pulmonary edema or congestive heart

    failure (eg, dyspnea with exertion, orthopnea,shortness of breath) may be present

  • 7/30/2019 Nephritis- urinary system disease

    6/18

    CLINICAL MANIFESTATIONS

    Gross hematuria (eg, dark, rust colored, coke

    colored, tea colored) may be present.

    With severe hypertension, identify nosebleed,

    headache, or encephalopathy.

  • 7/30/2019 Nephritis- urinary system disease

    7/18

    DIAGNOSTIC EVALUATION

    PHYSICAL EXAMINATION

    Elevated blood pressure is an important physical

    finding

    Look for edema

    The child may have a pale appearance

    Tachypnea, dyspnea, hepatic congestion, and gallop

    rhythm suggest fluid overload with congestive heartfailure

  • 7/30/2019 Nephritis- urinary system disease

    8/18

    DIAGNOSTIC EVALUATION CONTD..

    With tubulointerstitial nephritis (TIN), physicalfindings include maculopapular rash, joint pain(with flexion and extension), and fever

    LABORATORY STUDIES

    Electrolyte, creatinine, and blood urea nitrogen(BUN) levels

    Complete blood count (CBC)

    Urinalysis

    Urine culture

  • 7/30/2019 Nephritis- urinary system disease

    9/18

    DIAGNOSTIC EVALUATION CONTD..

    Lupus serologies Measurement of complement components (ie, C3,

    C4)

    Antistreptolysin-O (ASO) titer

    Anti-DNAase B

    Perinuclear antineutrophil cytoplasmic antibody (P-

    ANCA) measurement

    Cellular antineutrophil cytoplasmic antibody (C-

    ANCA) assessment

  • 7/30/2019 Nephritis- urinary system disease

    10/18

    DIAGANOSTIC EVALUATION CONTD..

    Serum IgA measurement

    Laboratory findings in tubulointerstitial

    nephritis (TIN) include hematuria,

    eosinophilia, sterile pyuria, low-grade

    proteinuria, eosinophiluria, and urinary white

    blood cell casts

  • 7/30/2019 Nephritis- urinary system disease

    11/18

    DIAGANOSTIC EVALUATION CONTD..

    IMAGING STUDIES

    Renal ultrasonography is usually performed to

    exclude other causes of hypertension and hematuria,

    such as renal artery stenosis (ie, small, abnormalkidney on one side)

    No imaging tests are sensitive or specific for TIN.

    Renal ultrasonography may show large kidney

  • 7/30/2019 Nephritis- urinary system disease

    12/18

    TREATMENT

    INPATIENT CARE

    Inpatient care is usually necessary only to manage

    severe hypertension or complications of acute or

    chronic renal failure (eg, dialysis access, uremicsyndrome, congestive heart failure, electrolyte

    abnormalities such as hyperkalemia and pericardial

    effusion)

  • 7/30/2019 Nephritis- urinary system disease

    13/18

    TREATMENT

    OUTPATIENT CARE

    Involve the use of antihypertensive, diuretics,

    and diet modification

    Outpatient therapy may involve dialysis in a

    child who develops end-stage renal disease

  • 7/30/2019 Nephritis- urinary system disease

    14/18

    TREATMENT

    DIET AND ACTIVITY

    Fluid restriction may prevent fluid overload

    Fluid restriction of 300 mL/m2/d plus losses may allow

    In patients with hypertension, sodium restriction to therecommended daily allowance (RDA) of 2-4 mEq/kg/d may aid

    in management In children with renal failure, potassium restriction is justified

    to prevent hyperkalemia

    A short-term high-carbohydrate diet may prevent catabolism

    of body protein as an energy source Calcium supplementation is useful to maintain normal serum

    calcium

  • 7/30/2019 Nephritis- urinary system disease

    15/18

  • 7/30/2019 Nephritis- urinary system disease

    16/18

    MEDICAL MANAGEMENT

    ACE Inhibitors

    Captopril, a competitive ACE inhibitor, prevents theconversion of angiotensin I to angiotensin II, a potentvasoconstrictor, increasing levels of plasma renin andreducing aldosterone secretion

    A competitive ACE inhibitor, enalapril reducesangiotensin II levels, decreasing aldosterone

    secretion. The drug lowers systemic arterial bloodpressure, reducing injury caused by elevated bloodpressure

  • 7/30/2019 Nephritis- urinary system disease

    17/18

    MEDICAL MANAGEMENT

    Angiotensin II Receptor Antagonists

    Losartan is a prototype ARB. It is specific for the type 1, as

    opposed to type 2, angiotensin receptor. It may induce more

    complete inhibition of the renin-angiotensin system than do

    ACE inhibitors

    Valsartan is a prodrug that directly antagonizes angiotensin II

    receptors. It displaces angiotensin II from the AT1 receptor

    and may lower blood pressure by antagonizing AT1-induced

    vasoconstriction, aldosterone release, catecholamine release,arginine vasopressin release, water intake, and hypertrophic

    responses

  • 7/30/2019 Nephritis- urinary system disease

    18/18

    MEDICAL MANAGEMENT

    Calcium Channel Blockers

    Calcium channel blockers, nifedipine causes peripheral arterial

    vasodilation by inhibiting calcium influx across vascular

    smooth-muscle cell membranes

    Beta Adrenergic Blockers

    Labetalol blocks alpha-1 beta 1-, and beta 2-adrenergic

    receptor sites, decreasing BP

    Propranolol has membrane-stabilizing activity and decreases

    automaticity of contractions. Propranolol is not suitable for

    emergency treatment of hypertension. Do not administer IV

    in hypertensive emergencies